Authors: VARNEY MA RAO SP JACHEC C DEAL C HESS SD DAGGETT LP LIN FF JOHNSON EC VELICELEBI G

Citation: Ma. Varney et al., PHARMACOLOGICAL CHARACTERIZATION OF THE HUMAN IONOTROPIC GLUTAMATE-RECEPTOR SUBTYPE GLUR3 STABLY EXPRESSED IN MAMMALIAN-CELLS, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 358-370

Authors: DAGGETT LP JOHNSON EC VARNEY MA LIN FF HESS SD DEAL CR JACHEC C LU CC KERNER JA LANDWEHRMEYER GB STANDAERT DG YOUNG AB HARPOLD MM VELICELEBI G

Citation: Lp. Daggett et al., THE HUMAN N-METHYL-D-ASPARTATE RECEPTOR 2C SUBUNIT - GENOMIC ANALYSIS, DISTRIBUTION IN HUMAN BRAIN, AND FUNCTIONAL EXPRESSION, Journal of neurochemistry, 71(5), 1998, pp. 1953-1968

Authors: LIN FF VARNEY M SACAAN SI JACHEC C DAGGETT LP RAO S FLOR P KUHN R KERNER JA STANDAERT D YOUNG AB VELICELEBI G

Citation: Ff. Lin et al., CLONING AND STABLE EXPRESSION OF THE MGLUR1B SUBTYPE OF HUMAN METABOTROPIC RECEPTORS AND PHARMACOLOGICAL COMPARISON WITH THE MGLUR5A SUBTYPE, Neuropharmacology, 36(7), 1997, pp. 917-931

Authors: LIN FF WASHBURN M VARNEY MA DAGGETT LP SKVORETZ R DEAL C LARIOSA K JACHEC C FULLER T LU CC MCCUE A HESS SD VELICELEBI G JOHNSON EC

Citation: Ff. Lin et al., FUNCTIONAL AND STABLE EXPRESSION OF THE HUMAN GLUR2-FLIP IONOTROPIC GLUTAMATE-RECEPTOR, Molecular biology of the cell, 7, 1996, pp. 3768-3768

Authors: VARNEY MA JACHEC C DEAL C HESS SD DAGGETT LP SKVORETZ R URCAN M MORRISON JH MORAN T JOHNSON EC VELICELEBI G

Citation: Ma. Varney et al., STABLE EXPRESSION AND CHARACTERIZATION OF RECOMBINANT HUMAN HETEROMERIC N-METHYL-D-ASPARTATE RECEPTOR SUBTYPES NMDAR1A 2A AND NMDAR1A/2B INMAMMALIAN-CELLS/, The Journal of pharmacology and experimental therapeutics, 279(1), 1996, pp. 367-378

Authors: DAGGETT LP SACAAN AI AKONG M RAO SP HESS SD LIAW C URRUTIA A JACHEC C ELLIS SB DREESSEN J KNOPFEL T LANDWEHRMEYER GB TESTA CM YOUNG AB VARNEY M JOHNSON EC VELICELEBI G

Citation: Lp. Daggett et al., MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPE-5, Neuropharmacology, 34(8), 1995, pp. 871-886